Selected financial data for H1 FY2025 / Polish
30.06.2026
See also
Synektik edges closer to demerger as Syn2bio files prospectus with KNF
- Corporate news
- Investor relations
Syn2bio publishes its first periodic report
- Investor relations
- Press releases
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations